BEPOTASTINE BESILATE
Generic: BEPOTASTINE BESILATE
Somerset TherapeuticsManufacturer
OPHTHALMICRoute
BEPOTASTINE BESILATEActive Substance
2024-08-14Original Approval
BEPOTASTINE BESILATE is FDA application ANDA217770, sponsored by SOMERSET THERAPS LLC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
HEPATIC FUNCTION ABNORMAL
13 reports
2
DIARRHOEA
12 reports
3
PYREXIA
12 reports
4
PRURITUS
10 reports
5
DECREASED APPETITE
9 reports
6
DRUG-INDUCED LIVER INJURY
9 reports
7
NAUSEA
9 reports
8
ALANINE AMINOTRANSFERASE INCREASED
8 reports
9
ASPARTATE AMINOTRANSFERASE INCREASED
8 reports
10
ERYTHEMA MULTIFORME
8 reports